glyburide has been researched along with Cognitive Decline in 2 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zubov, AS | 1 |
| Ivleva, IS | 1 |
| Pestereva, NS | 1 |
| Tiutiunnik, TV | 1 |
| Traktirov, DS | 1 |
| Karpenko, MN | 1 |
| Esmaeili, MH | 1 |
| Enayati, M | 1 |
| Khabbaz Abkenar, F | 1 |
| Ebrahimian, F | 1 |
| Salari, AA | 1 |
2 other studies available for glyburide and Cognitive Decline
| Article | Year |
|---|---|
Glibenclamide alters serotonin and dopamine levels in the rat striatum and hippocampus, reducing cognitive impairment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cognitive Dysfunction; Corpus Striatum; Dopamine; Glyburide | 2022 |
Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Type 2 | 2020 |